Swedisch Orphan Biovitrum GmbH
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 1
- Amount won alone
- €216,000 excl. VAT
- Period
- 29 September 2026 – 29 September 2026
Its main clients
- AOK Baden-Württemberg · 1 contract
Where and what
Supplies · 1
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 31 August 2028 re-tender around March 2028 |
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Efmoroctocog alfa sowie zum Wirkstoff Efanesoctocog alfa
AOK Baden-Württemberg framework agreement |
Swedisch Orphan Biovitrum GmbH 1 bid received |
€216,000 |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 29/09/2026 | Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Efmoroctocog alfa sowie zum Wirkstoff Efanesoctocog alfa | AOK Baden-Württemberg | €216,000 |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.